Medipharm Labs Corp T.LABS

SEDDS (self emulsifying drug delivery systems)

[alleyesonme]

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176699/     MPL has been chosen by Avicanna to manufacture its SEDDS capsules for Canadian and International commercialization. The formulations NOT the technology is proprietary. Some may recall mention of MPL's " water soluable self emulsifying" success mentioned in quarters past CC's or PR’s.. I think we can expect SEDDs technology to be applied through "global pharmaceutical partnerships" NDA's, ANDA's and most interesting ...505(b)(2).... candidates include:

• Drugs with new indications
• Drugs with changes in dosage form, strength, formulation, dosing regimen or route of administration
• New combination products
• Prodrugs of an existing drug
• In some cases, drugs with new active ingredient.                         CBD.  A.K.A Canabidol, FDA approved as EPIDIOLEX(current dosage form...oil).        Patients want pills... they are coming. 

[subaru1i]

An additional add on comment to your post:  From past P.R.'s LABS made mention they developed their own in house technology for water soluability which may compliment the SEDDS technology brought to LABS by Avicanna.   The LABS water soluability solution that LABS developed in house now is their proprietary and intellectual property.   They all come together to make

[Olaf123]

avcn has 110k left in cash, 4.3 Mil receivables, 8 mil payable and lost 1.2 mil last quarter

[alleyesonme]

Yeah, very vulnerable, I believe they are the next takeover target...12mil shares traded two weeks ago plunging the share price in half followed by a low volume recovery...someone knows something...point I am getting at earlier is the future of cannabinoid drugs are pill form...something that doesn't exist YET..I believe that is the plan...tight lipped for competitive advantage but I don't

[Olaf123]

I think they might buy part of it. Maybe mymedi and Seds. Pidduck stated he aims to buy profitable companies. We are not out of the wood yet, taking on other loses is risky.

[alleyesonme]

Completely agree....management has been clear "they will continue reviewing potential M&A opportunities "...which I don't support however we will see what they bring to the table....something is happening with avicanna....no mention of the latest deal which is significant is fishy..

[subaru1i]

AVCN is waiting for new drug approval, at least one, in Brazil.  That market is about 2/3 the size of the U.S. market and is key partner in BRICS due to their agricultural/food production assets as well.  Also, I believe AVCN has more cash than that, they just raised cash in Aug I believe.   As far as M&A activity, we can't always look down, be it taking over a smaller

[Olaf123]

1.2 mil is not alot. They are already rolling over their debts at higher interest rate and with penalties. I hope for them they can keep finding last minute cash infusions or lower their cost and higher gross margin very fast. If our CEO thinks this is synergistic and think he has the time to turn things around given our own cash constrain.. it is fine, but I don't like it.

[subaru1i]

Olaf123, LABS has no cash constraints.  CEO statements from last CC puts that to rest and a bonus, a plan to generate more cash in the near term.   What Avicanna does is their business but I will admit, being health/medical/pharma focused with a drug in the approval process in Brazil,  at least they have the right company profite IF LABS is looking to acquire again but then M